Translating tolerogenic therapies to the clinic - where do we stand?
about
Prospects for therapeutic tolerance in humans.Pathogenic and protective role of macrophages in kidney diseaseReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesTransplantation tolerance: from theory to clinic.Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC.Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.Tolerogenic dendritic cells and their applications in transplantationFacilitated Peptide Transport via the Mucosal Epithelium: Impact on Tolerance Induction.Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?Regulatory T cells as immunotherapy.Exploring cell-based tolerance strategies for hand and face transplantation.Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?Proceedings: Immune Tolerance and Stem Cell Transplantation: A CIRM Mini-Symposium and Workshop Report.The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
P2860
Q27318199-1AB5E94D-0874-436B-82FF-C1652EFA3E0FQ27690812-251E3287-AD50-4B24-AFED-52DECE2DDAA9Q28080994-4D2F3D59-4497-4CA1-BD10-EF2422AD9129Q34082059-7640C8D7-885B-4A86-84BF-279963194174Q35107474-689326E6-FC73-4648-848D-F4284371E504Q35593686-E134FE0E-C8B2-4B9E-9E8B-1F70421A4708Q36302853-83E5DF5B-2CB2-4050-893A-5F6570A08712Q37681115-398D4815-E151-4E2D-992E-9A95E117D32BQ38091722-07290A59-498F-4377-82C6-BE851E9732CBQ38191610-FAFF0D2F-7CF3-4C1B-BB74-4002BC9F1915Q38569715-1771E6ED-6E9F-4E10-88D0-53AB8E1AA86BQ38673525-BCB5F78E-D579-491F-92F2-976B1071637FQ42428575-DF513DA8-8AC9-474D-9B08-8E94B376101BQ42552506-739B292E-D298-4273-BEC5-2945996DD1ABQ48213485-797A7D9B-0F70-4A16-8E31-30896F6AC240
P2860
Translating tolerogenic therapies to the clinic - where do we stand?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Translating tolerogenic therapies to the clinic - where do we stand?
@en
type
label
Translating tolerogenic therapies to the clinic - where do we stand?
@en
prefLabel
Translating tolerogenic therapies to the clinic - where do we stand?
@en
P2860
P356
P1476
Translating tolerogenic therapies to the clinic - where do we stand?
@en
P2093
Kathryn J Wood
P2860
P356
10.3389/FIMMU.2012.00254
P577
2012-08-20T00:00:00Z